{"count": 2, "results": [{"_id": "20103024", "pmid": 20103024, "title": "Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.", "journal": "Am J Med", "authors": ["Schelleman H", "Bilker WB", "Brensinger CM", "Wan F", "Yang YX", "Hennessy S"], "date": "2010-02-01T00:00:00Z", "doi": "10.1016/j.amjmed.2009.07.020", "meta_date_publication": "2010 Feb", "meta_volume": "123", "meta_issue": "2", "meta_pages": "151-7", "score": 50053.414, "text_hl": "RESULTS: Chronic @CHEMICAL_Warfarin @CHEMICAL_MESH:D014859 @@@warfarin@@@ users had an increased odds ratio of @<m>DISEASE_Gastrointestinal_Hemorrhage</m> @DISEASE_MESH:D006471 @@@gastrointestinal bleeding@@@ upon initiation of @CHEMICAL_Gemfibrozil @CHEMICAL_MESH:D015248 @@@gemfibrozil@@@ (1.88; 95% confidence interval [CI], 1.00-3.54] for the first prescription; 1.75; 95% CI, 0.77-3.95 for the second prescription); @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (1.46; 95% CI, 1.03-2.07 for the first prescription; 1.60; 95% CI, 1.07-2.39 for the second prescription); or @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ (1.39; 95% CI, 1.07-1.81 for the first prescription; 1.05; 95% CI, 0.73-1.52 for the second prescription). ", "citations": {"NLM": "Schelleman H, Bilker WB, Brensinger CM, Wan F, Yang YX, Hennessy S. Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med. 2010 Feb;123(2):151-7. PMID: 20103024", "BibTeX": "@article{20103024, title={Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk.}, author={Schelleman H and Bilker WB and Brensinger CM and Wan F and Yang YX and Hennessy S}, journal={Am J Med}, volume={123}, number={2}, pages={151-7}}"}}, {"_id": "28445318", "pmid": 28445318, "pmcid": "PMC5413283", "title": "Renal failure caused by a partly calcified aortic aneurysm in a patient with dabigatran therapy", "journal": "Medicine (Baltimore)", "authors": ["Jud P", "Gary T", "Tiesenhausen K", "Portugaller R", "Hackl G", "Brodmann M"], "date": "2017-04-01T00:00:00Z", "doi": "10.1097/MD.0000000000006789", "meta_date_publication": "2017 Apr", "meta_volume": "96", "meta_issue": "17", "meta_pages": "e6789", "score": 50043.11, "text_hl": "Due to the @<m>DISEASE_Gastrointestinal_Hemorrhage</m> @DISEASE_MESH:D006471 @@@gastrointestinal bleeding@@@ and the persistent @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@impaired renal function@@@, @CHEMICAL_Dabigatran @CHEMICAL_MESH:D000069604 @@@dabigatran@@@ was stopped. ", "citations": {"NLM": "Jud P, Gary T, Tiesenhausen K, Portugaller R, Hackl G, Brodmann M. Renal failure caused by a partly calcified aortic aneurysm in a patient with dabigatran therapy Medicine (Baltimore). 2017 Apr;96(17):e6789. PMID: 28445318", "BibTeX": "@article{28445318, title={Renal failure caused by a partly calcified aortic aneurysm in a patient with dabigatran therapy}, author={Jud P and Gary T and Tiesenhausen K and Portugaller R and Hackl G and Brodmann M}, journal={Medicine (Baltimore)}, volume={96}, number={17}, pages={e6789}}"}}]}